IRAK1

From WikiMD's Medical Encyclopedia

Revision as of 05:45, 16 February 2025 by Prab (talk | contribs) (CSV import)

Interleukin-1 Receptor-Associated Kinase 1 (IRAK1)

File:IRAK1 Toll-like receptor pathways revised.jpg
Diagram of IRAK1 in Toll-like receptor pathways

Interleukin-1 Receptor-Associated Kinase 1 (IRAK1) is a critical kinase involved in the signaling pathways of the immune system. It plays a pivotal role in the Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling pathways, which are essential for the innate immune response.

Structure

IRAK1 is a serine/threonine kinase that is part of the IRAK family, which also includes IRAK2, IRAK3 (also known as IRAK-M), and IRAK4. The structure of IRAK1 includes an N-terminal death domain, a central kinase domain, and a C-terminal domain that is involved in protein-protein interactions.

Function

IRAK1 is activated upon the engagement of TLRs or IL-1R by their respective ligands. Upon activation, IRAK1 is recruited to the receptor complex through interactions with the adaptor protein MyD88. This recruitment leads to the phosphorylation and activation of IRAK1, which subsequently dissociates from the receptor complex and interacts with downstream signaling molecules such as TRAF6.

The activation of IRAK1 leads to the activation of the NF-_B and MAPK signaling pathways, resulting in the transcription of pro-inflammatory cytokines and other immune response genes.

Role in Disease

Dysregulation of IRAK1 activity has been implicated in various inflammatory and autoimmune diseases. Overactivation of IRAK1 can lead to excessive production of inflammatory cytokines, contributing to conditions such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease. Conversely, impaired IRAK1 function can result in increased susceptibility to infections.

Therapeutic Target

Given its central role in immune signaling, IRAK1 is considered a potential therapeutic target for the treatment of inflammatory and autoimmune diseases. Inhibitors of IRAK1 are being investigated for their ability to modulate immune responses and reduce inflammation.

Related Pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.